[Erratum to: Ocrelizumab for treatment of multiple sclerosis]. Graf J, Albrecht P, Goebels N, Aktas O, et al. Nervenarzt 2020 Jul 28. pii: 10.1007/s00115-020-00956.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Graf J, Albrecht P, Goebels N, Aktas O, et al. [Erratum to: Ocrelizumab for treatment of multiple sclerosis]. Nervenarzt 2020 Jul 28. pii: 10.1007/s00115-020-00956.
PMID: 32725489